Abstract
This article summarizes the morbidity and mortality associated with COPD and was created from a presentation given at the 130th AAIM Annual Meeting. The author reviews what most medical directors already know about COPD, but with particular attention paid to the Pulmonary Function Tests dealing with spirometry. Underwriters and medical directors need to understand the three basic measurements of spirometry (FVC, FEV1, and FEF25-75), as well as the significance of the FEV1/FVC ratio, in establishing an applicant as having an obstructive or restrictive impairment.
Publisher
American Academy of Insurance Medicine
Reference39 articles.
1. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade;Adeloye;J Global Health,2021
2. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study;GBD 2015 Chronic Respiratory Disease Collaborators.;Lancet Respir Med,2015
3. Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort;Bhatt;Radiology,2022
4. Changes in Forced Expiratory Volume in 1 second over time in COPD;Vestbo;N Engl J Med,2011
5. The Body-Mass Index, Airflow Obstruction Dyspnea, and Exercise capacity Index in Chronic Obstructive Pulmonary Disease;Celli;N Engl J Med,2004
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献